Risk factors for Candida tropicalis fungemia in patients with cancer

140Citations
Citations of this article
113Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The risk factors for and presentation of Candida tropicalis fungemia, in comparison with those of Candida albicans, have been incompletely characterized. We compared 43 cases of C. tropicalis fungemia with 148 cases of C. albicans fungemia. In univariate analysis, patients with C. tropicalis fungemia were more likely to have leukemia (P = .0006), prolonged neutropenia (P = .03), and a positive blood culture for more days (P = .02). The 2 groups did not differ with regard to baseline Acute Physiology and Chronic Health Evaluation (APACHE) II score, frequency of catheter-associated fungemia, or response to antifungals. In multivariate analysis, patients with C. tropicalis fungemia were more likely to have leukemia (P = .02), previous neutropenia (P = .002), and a longer stay in the intensive care unit during the infectious episode (P = .01). Also, the response of the breakthrough C. tropicalis fungemia was lower (P = .05). In conclusion, the host determinants associated with susceptibility to C. tropicalis are leukemia and prolonged neutropenia. © 2001 by the Infectious Diseases Society of America 2011.

Cite

CITATION STYLE

APA

Kontoyiannis, D. P., Vaziri, I., Hanna, H. A., Boktour, M., Thornby, J., Hachem, R., … Raad, I. I. (2001). Risk factors for Candida tropicalis fungemia in patients with cancer. Clinical Infectious Diseases, 33(10), 1676–1681. https://doi.org/10.1086/323812

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free